BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24144868)

  • 1. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic inflammatory myopathies.
    Amato AA; Griggs RC
    Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Katz JD; Jones OY
    Rheum Dis Clin North Am; 2013 Nov; 39(4):877-904. PubMed ID: 24182859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory myopathies.
    Amato AA; Greenberg SA
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
    Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
    Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment of the inflammatory myopathies.
    Dalakas MC
    Curr Opin Rheumatol; 1994 Nov; 6(6):595-601. PubMed ID: 7865379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on therapy for refractory dermatomyositis and polymyositis.
    Villalba L; Adams EM
    Curr Opin Rheumatol; 1996 Nov; 8(6):544-51. PubMed ID: 9018458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory myopathies: how to treat the difficult cases.
    Mastaglia FL; Zilko PJ
    J Clin Neurosci; 2003 Jan; 10(1):99-101. PubMed ID: 12464534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of inflammatory myopathies.
    Mastaglia FL; Laing BA; Zilko P
    Baillieres Clin Neurol; 1993 Nov; 2(3):717-40. PubMed ID: 8156149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory muscle diseases].
    Pongratz D
    Z Rheumatol; 1986; 45(4):133-8. PubMed ID: 3776360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory myopathies.
    Kingston WJ; Moxley RT
    Neurol Clin; 1988 Aug; 6(3):545-61. PubMed ID: 3065600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of inflammatory myopathies.
    Mastaglia FL; Phillips BA; Zilko P
    Muscle Nerve; 1997 Jun; 20(6):651-64. PubMed ID: 9149071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.
    Dalakas MC
    Neuromuscul Disord; 2006 Apr; 16(4):223-36. PubMed ID: 16542836
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.